較低的血壓目標可降低心臟病風險
Lower Blood Pressure Targets Reduce Heart Risk
近年來，現代心血管醫學採納了一種新的理念：較低的血壓目標可顯著降低心臟病風險。
In recent years, modern cardiovascular medicine has embraced a new philosophy: lower blood pressure targets significantly reduce heart risk.
在具有里程碑意義的SPRINT臨床試驗推動下—該研究涵蓋了超過9,000名成年人—證據顯示，將收縮壓強制控制在120 mm Hg以下，可使心臟病發作和中風等重大心血管事件減少25%。
Driven by the landmark SPRINT trial, which studied over 9,000 adults, evidence shows that an intensive systolic blood pressure target of under 120 mm Hg leads to a 25% reduction in major cardiovascular events like heart attacks and strokes.
因此，國際指引已經調整，許多組織現已建議將大多數成年人的血壓控制在130/80 mm Hg以下。
Consequently, international guidelines have shifted, with many now recommending a target of under 130/80 mm Hg for most adults.
除了心臟健康外，較低的收縮壓也與降低認知能力下降的風險有關。
Beyond heart health, lower systolic levels have been linked to a reduced risk of cognitive decline.
儘管這種「越低越好」的方法帶來明顯益處，但臨床醫師必須權衡潛在風險，如頭暈或腎臟損傷，特別是針對高齡患者。
While this 'lower is better' approach offers clear benefits, clinicians must weigh them against potential risks like dizziness or kidney injury, particularly in older patients.
成功的關鍵在於個人化治療、精確監測，以及藥物治療與健康生活方式改變的結合，例如DASH飲食和規律運動。
Success relies on individualized care, accurate monitoring, and a combination of medication and healthy lifestyle changes, such as the DASH diet and regular exercise.
透過優先重視持續的血壓管理，患者能夠顯著降低其長期健康風險。
By prioritizing consistent blood pressure management, patients can significantly lower their long-term health risks.
